Contact
Home • Our expertise • Territory expertise • Emerging markets

Emerging markets.

Understanding through experience.

Scroll

What we do.

Emerging markets offer exciting potential. However, these markets are uncertain, less understood, and constantly changing. How can global pharma hope to ensure success in these unchartered territories?

Our emerging markets team can help. One in three of our projects we manage cover one or more of the key countries ear-marked for growth. We carry out large-scale qualitative and quantitative studies across a range of therapy areas, throughout the product lifecycle, in China, Brazil India and beyond.

Emerging Markets
Your essential guide

Our dedicated experts have on-the-ground knowledge of the structural, cultural and environmental issues in emerging markets.

  • Expertise in over 60 + emerging markets
  • Completed over 300 + project in the last 3 years
  • Our 1 in 3 projects contain an emerging market
Download the digital guide.

Regional expertise.

ASEAN (Association of South East Nations)

Our emerging markets team has considerable expertise in the ASEAN markets, with our Asia headquarters located in Singapore, and can support your market research needs. We have conducted over 175 healthcare market research projects across ASEAN covering a wide variety of research objectives and over 30therapy areas, for both local and international organisations.

MENA (Middle East & North Africa)

MENA is comprised of many countries in the North of Africa and Middle East including Algeria, Egypt, Israel, Kingdom of Saudi Arabia, South Africa and United Arab Emirates. Our emerging markets team has considerable expertise in MENA having conducted over 135 projects in 15 Middle Eastern and Northern African and can support you with your market research needs.

North Asia

North Asia is comprised of China, Hong Kong, Japan, South Korea and Taiwan. With the exception of Hong Kong, the region’s healthcare systems are funded by the government and subsidised universally for their citizens offering coverage (to a varying extent) for in-patient service and ambulatory services. Our emerging markets team has conducted over 400 projects in the North Asian markets, with our Asia headquarters located in Singapore, and can support your market research needs.

Latin America

As the various economies within Latin America and the Caribbean continue to grow, the healthcare market in these regions present a wide range of opportunities for the pharmaceutical industry. We know these markets and understand their complexities and characteristics. We have conducted over 500 healthcare market research projects across Latin America and the Caribbean covering a wide variety of research objectives and therapy areas.

Find out more.

To find out more about our expertise in emerging markets, please contact us.

Our Emerging Markets experts.

Marc Yates

Senior Director Asia Pacific and Emerging Market

About Marc.

Marc is head of RP’s dedicated Emerging Markets division. He has thirty-five years of experience in market research and has specialized in healthcare research since 1996. Marc spent fifteen years in Asia, including postings in Shanghai, Hong Kong, and Singapore. In 2012, he relocated back to London to work closely with pharma companies looking to maximize ROI in emerging markets.

Marc is a regular speaker at industry events and has presented papers on Emerging Markets at EphMRA and PBIRG conferences.

marc.yates@researchpartnership.com